Chris Boone, global head of health economics and outcomes research at AbbVie, shares why pharmaceutical companies are still working to improve diversity in clinical trials. HIMSS21 Global By HIMSS TV | September 7, 2021 | 8:05 AM Tags: pharmaceutical, diversity, clinical trials, AbbVie